IMMUNOVANT SCIENCES GMBH – Trademark Portfolio
Entity Type: 27
IMMUNOVANT SCIENCES GMBH holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered and 6 are pending. Notable registered marks include IMMUNOVANT. The owner is based in BASEL.
VIADUKTSTRASSE 8
BASEL 4051 , CH
Showing of trademarks Trademarks
Trademark Classifications
IMMUNOVANT SCIENCES GMBH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does IMMUNOVANT SCIENCES GMBH have?
IMMUNOVANT SCIENCES GMBH has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 pending, 1 abandoned, 2 cancelled.
What trademark classes does IMMUNOVANT SCIENCES GMBH file in?
IMMUNOVANT SCIENCES GMBH files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are IMMUNOVANT SCIENCES GMBH's most well-known trademarks?
IMMUNOVANT SCIENCES GMBH's registered trademark portfolio includes well-known marks such as IMMUNOVANT. These are among 1 currently registered trademark in the portfolio.
What is IMMUNOVANT SCIENCES GMBH's trademark registration success rate?
IMMUNOVANT SCIENCES GMBH has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 6 applications are pending review.